3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Myeloid
1
CNS
1
Conditions
Lymphoma
149
Lymphoma, Large B-Cell, Diffuse
114
Lymphoma, Non-Hodgkin
110
Precursor Cell Lymphoblastic Leukemia-Lymphoma
106
Leukemia
81
Hodgkin Disease
81
Small Cell Lung Carcinoma
79
Leukemia, Myeloid, Acute
73
Burkitt Lymphoma
69
Lymphoma, Follicular
67
Lymphoma, Mantle-Cell
65
Lung Neoplasms
60
Lymphoma, Large-Cell, Immunoblastic
54
Leukemia, Lymphocytic, Chronic, B-Cell
47
Recurrence
40
Multiple Myeloma
39
Lymphoma, B-Cell, Marginal Zone
36
Neuroblastoma
33
Congenital Abnormalities
29
Carcinoma, Non-Small-Cell Lung
28
Lymphoma, B-Cell
25
Myelodysplastic Syndromes
24
Lymphoma, Large-Cell, Anaplastic
23
Lymphoma, Extranodal NK-T-Cell
23
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
22
Brain Neoplasms
22
Sarcoma
21
Ovarian Neoplasms
21
Lymphoma, T-Cell, Peripheral
20
Central Nervous System Neoplasms
20
Interventions
fludarabine
3
Tacrolimus
3
Melphalan
3
Cyclophosphamide
3
Busulfan
3
thymoglobulin
2
fludarabine phosphate
2
Whole-Body Irradiation
2
Rituximab
2
Mycophenolic Acid
2
Clofarabine
2
Antilymphocyte Serum
2
trametinib
1
etoposide phosphate
1
dabrafenib
1
cobimetinib
1
Thiotepa
1
Specimen Handling
1
Sirolimus
1
Peripheral Blood Stem Cell Transplantation
1
Methylprednisolone Hemisuccinate
1
Methylprednisolone
1
Magnetic Resonance Spectroscopy
1
Lenalidomide
1
Granulocyte Colony-Stimulating Factor
1
Genetic Testing
1
Filgrastim
1
Etoposide
1
Enzyme-Linked Immunosorbent Assay
1
Deferasirox
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Histiocytosis, Langerhans-Cell
×
Etoposide
×
Clear all
NCT02574728
2026-03-02
AflacST1502
Emory University
Phase 2
Active not recruiting
46 enrolled